Pamela P. Palmer, Chief Medical Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 8,800 shares at $4.61 ($41K) on 2011-06-09, disclosed to the SEC on 2011-06-13.
Open-market purchase of $41k ACRX by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ACRX | BUY | 2018-11-19 | $49K | — | Filing → |
| ACRX | BUY | 2018-08-06 | $102K | — | Filing → |
| ACRX | BUY | 2017-08-22 | $30K | — | Filing → |